Amanta Healthcare Ltd
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Capacity Utilization - LVP (excl. SteriPort) % ・Standalone data |
|
||||
| Capacity Utilization - SteriPort % ・Standalone data |
|||||
| Installed Capacity - SteriPort (LVP) Crore bottles per year ・Standalone data |
|||||
| Installed Capacity - SVP Crore bottles per year ・Standalone data |
|||||
| Active Export Countries count ・Standalone data |
|||||
| Capacity Utilization - SVP % ・Standalone data |
|||||
| Product Portfolio count ・Standalone data |
|||||
| International Product Registration Jurisdictions count ・Standalone data |
|||||
| Number of Distributors & Stockists count ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
-
Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015 - Off Market Transfer Of Equity Shares
- Regulation 7(2) disclosure filed for promoter group off-market equity share transfer.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Concalls
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT
Business Profile:[1][2]
Amanta Healthcare is a niche pharmaceutical company specializing in sterile liquid parenteral (injections and infusions) using ABFS and ISBM technologies. It operates across six therapeutic segments: fluid therapy, diluents and injectables, ophthalmic, respiratory solutions, irrigation, and other formulations.
As an integrated LVP and SVP manufacturer,
its products support critical care in oncology, pediatrics, ICU, and anesthesia. Under its “SteriPort” brand for two-port IV systems, management estimates a 50–60% domestic market share in PP IV bottles.